Egyptian Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Applications

RESULTS: To develop our national pharmacoeconomic guidelines, three steps were taken. First, the focus group reviewed the EUnetHTA methods for health economic evaluations for pharmaceuticals as well as the Canadian Agency for Drugs and Technologies in Health (CADTH) guidelines and the Academy of Managed Care Pharmacy (AMCP) Format for Formulary Submissions. Second, the focus group used the EUnetHTA guideline as a reference and adapted it to our local context. The focus group added the value assessment component using the CADTH and AMCP guidelines. Third, the focus group collected input and feedback from key stakeholders by using the quasi-Delphi panel approach. Economic evaluation is a core element of HTA; therefore, the UHIA and UPA were encouraged to produce unified joint pharmacoeconomic guidelines for innovative products as an initial step in their commitment to implement the use of HTA in decision-making.